Your browser doesn't support javascript.
loading
Effect of 177Lu-iPSMA on viability and DNA damage of human glioma cells subjected to hypoxia-mimetic conditions.
Azorín-Vega, Erika; Aranda-Lara, Liliana; Torres-García, Eugenio; Santiago-Bañuelos, Juan Antonio.
Afiliación
  • Azorín-Vega E; Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, 52750, Estado de México, Mexico.
  • Aranda-Lara L; Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180, Estado de México, Mexico. Electronic address: larandal@uaemex.mx.
  • Torres-García E; Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, 50180, Estado de México, Mexico.
  • Santiago-Bañuelos JA; Departamento de Materiales Radiactivos, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac, 52750, Estado de México, Mexico; Escuela Superior de Física y Matemáticas, Instituto Politécnico Nacional, Ciudad de México, 07738, Mexico.
Appl Radiat Isot ; 146: 24-28, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30743222
ABSTRACT
The therapeutic potential of 177Lu-iPSMA on hypoxic cancer cells has not been yet demonstrated. The aim of this work was to evaluate the radiation dose effect of 177Lu-iPSMA on viability and DNA damage in U87MG human glioma cells subjected to hypoxia-mimetic conditions. U87MG cells treated with 177Lu-iPSMA were incubated with CoCl2 in order to induce hypoxia-mimetic conditions. The cytotoxic and genotoxic effect was evaluated with an in vitro viability test and a neutral comet assay. 177Lu-iPSMA decreased the cell viability and induced DNA double strand breaks in U87MG human glioma cells under hypoxia-mimetic conditions. 177Lu-iPSMA produced the maximum effect at 48 h, suggesting that this radiopharmaceutical could be used as a strategy for the treatment of human glioma hypoxic cells.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Radioisótopos / Glutamato Carboxipeptidasa II / Glioma / Lutecio Límite: Humans Idioma: En Revista: Appl Radiat Isot Asunto de la revista: MEDICINA NUCLEAR / SAUDE AMBIENTAL Año: 2019 Tipo del documento: Article País de afiliación: México

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Radioisótopos / Glutamato Carboxipeptidasa II / Glioma / Lutecio Límite: Humans Idioma: En Revista: Appl Radiat Isot Asunto de la revista: MEDICINA NUCLEAR / SAUDE AMBIENTAL Año: 2019 Tipo del documento: Article País de afiliación: México